The path of new drugs to the patient can take up to 4 years
The Ministry of Industry and Trade, together with domestic pharmaceutical companies, proposes to create a mechanism providing for an extraordinary review of clinical recommendations for Russian drugs included in the list of vital and essential drugs (VEDs).

The Ministry of Industry and Trade, together with domestic pharmaceutical companies, proposes to create a mechanism providing for an extraordinary review of clinical recommendations for Russian drugs included in the list of vital and essential drugs (VEDs).



